Figure 2.
Effects of Resmetirom, as reported by the MAESTRO-NAFLD-1 trial. Only selected effects from the study (7) are depicted. Figure created with Biorender.com. BP, blood pressure; FT3, free triiodothyronine; FT4, free thyroxine; HDL, high density lipoprotein; MASLD, metabolic dysfunction-associated steatotic liver disease; RLP, remnant-like particle; SHBG, sex hormone-binding globulin; TSH, thyroid-stimulating hormone; VLDL, very low-density lipoprotein.